In the last 12 months, insiders at CEL SCI CORP ($CVM) filed 68 transactions with the SEC: 7 open-market purchases totaling $550,614 and 0 sales totaling $0. Net insider sentiment: net buying.
CEL SCI CORP operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- KERSTEN GEERT R (Chief Executive Officer) — 20 transactions totaling $557,758
- Watson Robert Eugene (Director) — 5 transactions totaling $47,795
- PRICHEP PATRICIA B (Senior Vice President) — 10 transactions totaling $41,147
- TALOR EYAL (Chief Scientific Officer) — 17 transactions totaling $33,582
- PRICHEP PATRICIA B (Chief Financial Officer) — 6 transactions totaling $20,707
View all SEC Filings for CEL SCI CORP (CVM).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | KERSTEN GEERT R | Chief Executive Officer | A | Common Stock | 1682 | $3.21 | 122,497.0000 | 94,037,256 | 1.39% | 0.00% |
| March 31, 2026 | TALOR EYAL | Chief Scientific Officer | A | Common Stock | 747 | $3.21 | 7,011.0000 | 94,037,256 | 11.93% | 0.00% |
| March 31, 2026 | PRICHEP PATRICIA B | Chief Financial Officer | A | Common Stock | 1336 | $3.21 | 13,364.0000 | 94,037,256 | 11.11% | 0.00% |
| Jan. 22, 2026 | KERSTEN GEERT R | Chief Executive Officer | P | Common Stock | 38023 | $5.26 | 120,815.0000 | 94,037,256 | 45.93% | 0.04% |
| Dec. 31, 2025 | PRICHEP PATRICIA B | Chief Financial Officer | A | Common Stock | 815 | $5.26 | 12,028.0000 | 94,037,256 | 7.27% | 0.00% |
| Dec. 31, 2025 | TALOR EYAL | Chief Scientific Officer | A | Common Stock | 456 | $5.26 | 6,264.0000 | 94,037,256 | 7.85% | 0.00% |
| Dec. 31, 2025 | KERSTEN GEERT R | Chief Executive Officer | A | Common Stock | 998 | $5.26 | 82,792.0000 | 94,037,256 | 1.22% | 0.00% |
| Dec. 4, 2025 | KERSTEN GEERT R | Chief Executive Officer | P | Common Stock | 8389 | $5.96 | 81,794.0000 | 94,037,256 | 11.43% | 0.01% |
| Sept. 30, 2025 | PRICHEP PATRICIA B | Chief Financial Officer | A | Common Stock | 466 | $9.20 | 11,213.0000 | 94,037,256 | 4.34% | 0.00% |
| Sept. 30, 2025 | KERSTEN GEERT R | Chief Executive Officer | A | Common Stock | 570 | $9.20 | 73,405.0000 | 94,037,256 | 0.78% | 0.00% |
| Sept. 30, 2025 | TALOR EYAL | Chief Scientific Officer | A | Common Stock | 260 | $9.20 | 5,808.0000 | 94,037,256 | 4.69% | 0.00% |
| July 28, 2025 | KERSTEN GEERT R | Chief Executive Officer | A | Options | 25000 | $0.01 | 175,157.0000 | 94,037,256 | 16.65% | 0.03% |
| July 28, 2025 | TALOR EYAL | Chief Scientific Officer | A | Options | 15000 | $0.01 | 81,622.0000 | 94,037,256 | 22.52% | 0.02% |
| July 28, 2025 | PRICHEP PATRICIA B | Chief Financial Officer | A | Options | 12000 | $0.01 | 75,127.0000 | 94,037,256 | 19.01% | 0.01% |
| July 25, 2025 | Watson Robert Eugene | Director | P | Common Stock | 2919 | $6.85 | 3,733.0000 | 94,037,256 | 358.60% | 0.00% |
| July 28, 2025 | Watson Robert Eugene | Director | A | Options | 4000 | $0.01 | 27,266.0000 | 94,037,256 | 17.19% | 0.00% |
| July 28, 2025 | BAILLAVOINE BRUNO JEAN-MARIE | Director | A | Options | 4000 | $0.01 | 28,017.0000 | 94,037,256 | 16.65% | 0.00% |
| July 28, 2025 | CIPRIANO JOHN | Senior Vice President | A | Options | 7500 | $0.01 | 38,008.0000 | 94,037,256 | 24.58% | 0.01% |
| July 25, 2025 | KERSTEN GEERT R | Chief Executive Officer | P | Common Stock | 29197 | $6.85 | 72,835.0000 | 94,037,256 | 66.91% | 0.03% |
| June 30, 2025 | PRICHEP PATRICIA B | Chief Financial Officer | A | Common Stock | 1873 | $2.29 | 10,747.0000 | 2,126,682 | 21.11% | 0.09% |
| June 30, 2025 | TALOR EYAL | Chief Scientific Officer | A | Common Stock | 1048 | $2.29 | 5,548.0000 | 2,126,682 | 23.29% | 0.05% |
| June 30, 2025 | KERSTEN GEERT R | Chief Executive Officer | A | Common Stock | 2292 | $2.29 | 43,638.0000 | 2,126,682 | 5.54% | 0.11% |
| March 31, 2025 | TALOR EYAL | Chief Scientific Officer | A | Common Stock | 10416 | $0.23 | 135,013.0000 | 2,126,682 | 8.36% | 0.49% |
| March 31, 2025 | PRICHEP PATRICIA B | Chief Financial Officer | A | Common Stock | 15432 | $0.23 | 266,230.0000 | 2,126,682 | 6.15% | 0.73% |
| March 31, 2025 | KERSTEN GEERT R | Chief Executive Officer | A | Common Stock | 22786 | $0.23 | 1,240,378.0000 | 2,126,682 | 1.87% | 1.07% |
| Dec. 31, 2024 | PRICHEP PATRICIA B | Chief Financial & Operations | A | Common Stock | 10727 | $0.40 | 250,798.0000 | 2,126,682 | 4.47% | 0.50% |
| Dec. 31, 2024 | KERSTEN GEERT R | CEO | A | Common Stock | 12940 | $0.40 | 1,217,592.0000 | 2,126,682 | 1.07% | 0.61% |
| Dec. 31, 2024 | TALOR EYAL | Chief Scientific Officer | A | Common Stock | 6001 | $0.40 | 124,597.0000 | 2,126,682 | 5.06% | 0.28% |
| Sept. 30, 2024 | PRICHEP PATRICIA B | Sr. VP of Operations | A | Common Stock | 4047 | $1.06 | 240,071.0000 | 0 | 1.71% | 0.00% |
| Sept. 30, 2024 | KERSTEN GEERT R | Chief Executive Officer | A | Common Stock | 4882 | $1.06 | 1,204,652.0000 | 0 | 0.41% | 0.00% |
| Sept. 30, 2024 | TALOR EYAL | Chief Scientific Officer | A | Common Stock | 2264 | $1.06 | 118,596.0000 | 0 | 1.95% | 0.00% |
| June 28, 2024 | PRICHEP PATRICIA B | Senior Vice President | A | Common Stock | 3698 | $1.16 | 236,024.0000 | 0 | 1.59% | 0.00% |
| June 28, 2024 | KERSTEN GEERT R | Chief Executive Officer | A | Common Stock | 4461 | $1.16 | 1,199,770.0000 | 0 | 0.37% | 0.00% |
| June 28, 2024 | TALOR EYAL | Chief Scientific Officer | A | Common Stock | 2068 | $1.16 | 116,332.0000 | 0 | 1.81% | 0.00% |
| May 8, 2024 | Watson Robert Eugene | Director | P | Common Stock | 20000 | $1.39 | 24,431.0000 | 0 | 451.37% | 0.00% |
| May 8, 2024 | KERSTEN GEERT R | Chief Executive Officer | P | Common Stock | 30000 | $1.39 | 1,195,309.0000 | 0 | 2.57% | 0.00% |
| May 8, 2024 | PRICHEP PATRICIA B | Senior Vice President | P | Common Stock | 8000 | $1.39 | 232,326.0000 | 0 | 3.57% | 0.00% |
| April 19, 2024 | KERSTEN GEERT R | Chief Executive Officer | A | Options | 250000 | $0.01 | 4,504,709.0000 | 0 | 5.88% | 0.00% |
| April 19, 2024 | PRICHEP PATRICIA B | Senior Vice President | A | Options | 167000 | $0.01 | 1,893,797.0000 | 0 | 9.67% | 0.00% |
| April 19, 2024 | TALOR EYAL | Chief Scientific Officer | A | Options | 182000 | $0.01 | 1,998,646.0000 | 0 | 10.02% | 0.00% |
| April 19, 2024 | BAILLAVOINE BRUNO JEAN-MARIE | Director | A | Options | 64000 | $0.01 | 725,500.0000 | 0 | 9.67% | 0.00% |
| April 19, 2024 | Watson Robert Eugene | Director | A | Options | 64000 | $0.01 | 698,000.0000 | 0 | 10.09% | 0.00% |
| March 29, 2024 | KERSTEN GEERT R | Chief Executive Officer | A | Common Stock | 2709 | $1.91 | 1,165,309.0000 | 0 | 0.23% | 0.00% |
| March 29, 2024 | PRICHEP PATRICIA B | Senior Vice President | A | Common Stock | 2246 | $1.91 | 224,326.0000 | 0 | 1.01% | 0.00% |
| March 29, 2024 | TALOR EYAL | Chief Scientific Officer | A | Common Stock | 1256 | $1.91 | 114,264.0000 | 0 | 1.11% | 0.00% |
| Dec. 29, 2023 | TALOR EYAL | Chief Scientific Officer | A | Common Stock | 882 | $2.72 | 113,008.0000 | 0 | 0.79% | 0.00% |
| Dec. 29, 2023 | PRICHEP PATRICIA B | Senior Vice President | A | Common Stock | 1577 | $2.72 | 222,080.0000 | 0 | 0.72% | 0.00% |
| Dec. 29, 2023 | KERSTEN GEERT R | Chief Executive Officer | A | Common Stock | 1819 | $2.72 | 1,162,600.0000 | 0 | 0.16% | 0.00% |
| Sept. 29, 2023 | TALOR EYAL | Chief Scientific Officer | A | Common Stock | 1920 | $1.25 | 112,126.0000 | 0 | 1.74% | 0.00% |
| Sept. 29, 2023 | PRICHEP PATRICIA B | Senior Vice President | A | Common Stock | 3432 | $1.25 | 220,503.0000 | 0 | 1.58% | 0.00% |
| Sept. 29, 2023 | KERSTEN GEERT R | Chief Executive Officer | A | Common Stock | 3960 | $1.25 | 1,160,781.0000 | 0 | 0.34% | 0.00% |
| Aug. 8, 2023 | TALOR EYAL | Chief Scientific Officer | A | Options | 182000 | $0.01 | 1,819,046.0000 | 0 | 11.12% | 0.00% |
| Aug. 8, 2023 | PRICHEP PATRICIA B | Senior Vice President | A | Options | 167000 | $0.01 | 1,729,197.0000 | 0 | 10.69% | 0.00% |
| Aug. 8, 2023 | KERSTEN GEERT R | Chief Executive Officer | A | Options | 250000 | $0.01 | 4,258,309.0000 | 0 | 6.24% | 0.00% |
| Aug. 8, 2023 | CIPRIANO JOHN | Senior Vice President | A | Options | 65000 | $0.01 | 917,027.0000 | 0 | 7.63% | 0.00% |
| Aug. 8, 2023 | YOUNG PETER R | Director | A | Options | 64000 | $0.01 | 667,300.0000 | 0 | 10.61% | 0.00% |
| Aug. 8, 2023 | BAILLAVOINE BRUNO JEAN-MARIE | Director | A | Options | 64000 | $0.01 | 661,500.0000 | 0 | 10.71% | 0.00% |
| Aug. 8, 2023 | Watson Robert Eugene | Director | A | Options | 64000 | $0.01 | 634,000.0000 | 0 | 11.23% | 0.00% |
| Aug. 8, 2023 | Naughton Gail K | Director | A | Options | 85000 | $0.01 | 149,000.0000 | 0 | 132.81% | 0.00% |
| June 30, 2023 | PRICHEP PATRICIA B | Senior Vice President | A | Common Stock | 1780 | $2.41 | 217,071.0000 | 0 | 0.83% | 0.00% |
| June 30, 2023 | TALOR EYAL | Chief Scientific Officer | A | Common Stock | 995 | $2.41 | 110,206.0000 | 0 | 0.91% | 0.00% |
| June 30, 2023 | KERSTEN GEERT R | Chief Executive Officer | A | Common Stock | 2053 | $2.41 | 1,156,821.0000 | 0 | 0.18% | 0.00% |
| March 31, 2023 | KERSTEN GEERT R | Chief Executive Officer | A | Common Stock | 2133 | $2.32 | 1,154,768.0000 | 0 | 0.19% | 0.00% |
| March 31, 2023 | TALOR EYAL | Chief Scientific Officer | A | Common Stock | 1034 | $2.32 | 109,211.0000 | 0 | 0.96% | 0.00% |
| March 31, 2023 | PRICHEP PATRICIA B | Senior Vice President | A | Common Stock | 1849 | $2.32 | 215,291.0000 | 0 | 0.87% | 0.00% |
| Dec. 30, 2022 | PRICHEP PATRICIA B | Senior Vice President | A | Common Stock | 1825 | $2.35 | 213,442.0000 | 0 | 0.86% | 0.00% |
| Dec. 30, 2022 | TALOR EYAL | Chief Scientific Officer | A | Common Stock | 1021 | $2.35 | 108,177.0000 | 0 | 0.95% | 0.00% |
| Dec. 30, 2022 | KERSTEN GEERT R | Chief Executive Officer | A | Common Stock | 1851 | $2.35 | 1,152,635.0000 | 0 | 0.16% | 0.00% |